SCR 64: Drug abuse awareness.
- Session Year: 2019-2020
- House: Senate
- Latest Version Date: 2019-09-09
|
Date
|
Status
|
|---|---|
| Sep 9, 2019 | Chaptered by Secretary of State. Res. Chapter 141, Statutes of 2019. |
| Sep 9, 2019 | Enrolled and filed with the Secretary of State at 3 p.m. |
| Aug 30, 2019 | In Senate. Ordered to engrossing and enrolling. |
| Aug 30, 2019 | Read. Adopted. Ordered to the Senate. |
| Aug 26, 2019 | From committee: Be adopted. Ordered to consent calendar. (Ayes 11. Noes 0.) (August 26). |
| Aug 22, 2019 | Referred to Com. on RLS. |
| Aug 19, 2019 | In Assembly. Held at Desk. |
| Aug 19, 2019 | Read. Adopted. (Ayes 40. Noes 0.) Ordered to the Assembly. |
| Aug 14, 2019 | From committee: Ordered to third reading. |
| Aug 12, 2019 | Introduced. Referred to Com. on RLS. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 30, 2019 | SCR 64 Bates Consent Calendar Second Day Regular Session | Assembly Floor |
Passed |
|
| Aug 26, 2019 | Be adopted. To Consent Calendar. | Assembly Standing Committee on Rules |
Passed |
|
| Aug 19, 2019 | Senate 3rd Reading SCR64 Bates et al. | Senate Floor |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Date of Hearing: August 26, 2019
ASSEMBLY COMMITTEE ON RULES
Ken Cooley, Chair
SBPCA Bill Id:SCR 64
Author:(Bates) – As Introduced Ver:August 12, 2019
SENATE VOTE: 40-0
SUBJECT: Drug abuse awareness
SUMMARY: Designates the month of September 2019 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month. Specifically, this resolution makes the following legislative findings:
- Between 2006 and 2012, pharmaceutical companies produced 76 billion opioids that were distributed in the United States. In 2017, more than 21 million opioid prescriptions were written in California.
- From 1999 to 2017, inclusive, almost 400,000 people died from overdoses related to opioids. Drug overdoses kill more people in one year than do the number of motor vehicle fatalities in the United States. Aggregate annual costs for prescription opioid overdose, abuse, and dependence were estimated at over $78.5 billion in 2013.
- The use of fentanyl is on the rise, with nearly seven times more confiscations of fentanyl from 2012 to 2014, inclusive, totaling 4,585 in 2014, according to the National Forensic Laboratory Information System. Fentanyl is 50 times more potent than heroin and 100 times more powerful than morphine, according to the federal Centers for Disease Control and Prevention.
- Many teens and young adults first use opioids when they are prescribed to them following an injury or routine procedure like the removal of wisdom teeth. Seventy-five percent of new heroin users were first addicted to a legally prescribed prescription opioid. Opioid use and misuse can create brain changes that lead to addiction.
- Most people who are addicted to opioids cannot taper off, or use less of the drug over time, without help. The long-term damage to individuals and families is highly detrimental.
- The Centers for Disease Control and Prevention recommends nonopioid pharmacologic therapy and if opioids are used, they should be combined with nonopioid therapy, as appropriate. In 2016, the federal Interagency Pain Research Coordinating Committee developed a National Pain Strategy, noting that effective pain care must emphasize shared decision making, informed pain assessment, and integrated, multimodal, and interdisciplinary treatment approaches that balance effectiveness with safety.
- Each year, a week in September is designated as national Prescription Opioid and Heroin Epidemic Awareness Week.
FISCAL EFFECT: None
REGISTERED SUPPORT / OPPOSITION:
Support
None on file
Opposition
None on file
Analysis Prepared by: Nicole Willis / RLS. / (916) 319-2800
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SCR 64 |
THIRD READING
Bill No: SCR 64
Introduced: 8/12/19
SOURCE: California Chiropractic Association
DIGEST:
This resolution designates the month of September 2019 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month.
ANALYSIS: This resolution makes the following legislative findings:
- Between 2006 and 2012, pharmaceutical companies produced 76 billion opioids that were distributed in the United States. In 2017, more than 21 million opioid prescriptions were written in California.
- From 1999 to 2017, inclusive, almost 400,000 people died from overdoses related to opioids. Drug overdoses kill more people in one year than do the number of motor vehicle fatalities in the United States. Aggregate annual costs for prescription opioid overdose, abuse, and dependence were estimated at over $78.5 billion in 2013.
- The use of fentanyl is on the rise, with nearly seven times more confiscations of fentanyl from 2012 to 2014, inclusive, totaling 4,585 in 2014, according to the National Forensic Laboratory Information System. Fentanyl is 50 times more potent than heroin and 100 times more powerful than morphine, according to the federal Centers for Disease Control and Prevention.
- Many teens and young adults first use opioids when they are prescribed to them following an injury or routine procedure like the removal of wisdom teeth. Seventy-five percent of new heroin users were first addicted to a legally prescribed prescription opioid. Opioid use and misuse can create brain changes that lead to addiction.
- Most people who are addicted to opioids cannot taper off, or use less of the drug over time, without help. The long-term damage to individuals and families is highly detrimental.
- The Centers for Disease Control and Prevention recommends nonopioid pharmacologic therapy and if opioids are used, they should be combined with nonopioid therapy, as appropriate. In 2016, the federal Interagency Pain Research Coordinating Committee developed a National Pain Strategy, noting that effective pain care must emphasize shared decisionmaking, informed pain assessment, and integrated, multimodal, and interdisciplinary treatment approaches that balance effectiveness with safety.
- Each year, a week in September is designated as national Prescription Opioid and Heroin Epidemic Awareness Week.
This resolution designates the month of September 2019 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month and encourages residents to show support for opioid and prescription drug awareness.
Related/Prior Legislation
SCR 68 (Bates, Resolution Chapter 157, Statutes of 2017) designated the month of September 2017 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month, as specified.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
California Chiropractic Association (source)
OPPOSITION: (Verified 8/13/19)
None received
ARGUMENTS IN SUPPORT: The California Chiropractic Association states in support:
Over the last 15 years, there has been a dramatic increase in the acceptance and use of prescription opioids for the treatment of non-cancer pain despite serious risks and a lack of evidence about their long-term effectiveness. In the United States, there have been 400,000 deaths between 1999 and 2017 from overdoses related to prescription opioids. In 2017, there were over 70,000 drug overdose deaths, with over 17,000 of these involving prescription opioids.
The sheer magnitude of America’s prescription opioid abuse has evoked visceral responses and calls to action from the public and private sectors. Opioid prescribing guidelines, like the CDC’s Guideline for Prescribing Opioids for Chronic Pain , already recommend the exploration of non-opioid therapeutic options and if opioids are prescribed they should be combined with non-opioid therapies. The California Health Care Foundation’s (CHCF) Changing Course: The Role of Health Plans in Curbing the Opioid Epidemic states that alternative treatments to opioids, including chiropractic care, have been found to play an important role in the delivery of cost-effective, non-drug services in both acute and chronic stages, as complementary to traditional treatments.
With a continued drug abuse epidemic in our country, SCR 64 puts a much needed spotlight on the issue. In order to adequately address the crisis in California, we must look at evidenced based pain management treatment options, like non-pharmacological providers, as well as other mechanisms designed to stop addiction in the first place. CalChiro has and will continue to be active participants in solving the prescription opioid addiction crisis.
Prepared by: Jonas Austin / SFA / (916) 651-1520
8/14/19 14:37:30
**** END ****
Bill Author
Bill Co-Author(s):